ABPI

R&D

One year on: How is the UK’s vision of a future-proof resear...

One year ago, a UK-wide vision for the country’s future research landscape promised streamlined processes, and a patient-centred, competitive environment.

Digital

Do skills gaps and the COVID brain drain threaten digital tr...

With staff shortages and digital skill gaps being experienced across the spectrum of healthcare, from CROs and pharma to providers, the people-led sector is facing a personnel challenge tha

Market Access

Post-Brexit medicines regulation must have international sco...

Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left behind.

Market Access

Are we measuring what matters most on uptake to medicines in...

In the second of a two-part series, Leela Barham argues that whilst international comparisons of uptake are useful, there could be more to gain from looking at more medicines and their upta

Market Access

Getting better at measuring international uptake of medicine...

In part one of a two-piece series, Leela Barham looks at whether we are getting better at measuring international uptake of medicines.

News

Industry welcomes boost to health research in UK budget

Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £

One year on: How is the UK’s vision of a future-proof resear...

Do skills gaps and the COVID brain drain threaten digital tr...

Post-Brexit medicines regulation must have international sco...

Are we measuring what matters most on uptake to medicines in...

Getting better at measuring international uptake of medicine...

Industry welcomes boost to health research in UK budget

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

ABPI

Editor's Picks